MD Buyline Pioneers Improved Healthcare Decision Making with Big Data Solution Powered by IBM Watson

A new era of cognitive computing will help healthcare providers make more informed, intelligent decisions and inspire healthier organizations and patients.

DALLAS, TX — November 15, 2013 — MD Buyline, Inc. and IBM (NYSE: IBM) announced today a partnership utilizing the IBM Watson cognitive computing system to help improve decision-making processes in hospitals to enable better patient care and outcomes. MD Buyline and IBM will showcase a prototype of the Big Data solution Hippocrates powered by IBM Watson during the IBM Watson Summit 2013 in Austin, Texas. Leveraging Watson’s cognitive abilities, Hippocrates acts as a decision adviser, uncovering the data-driven evidence that health systems and healthcare professionals need to make important decisions in real time.

MD Buyline is a key partner within a new ecosystem of businesses that will create apps infused with IBM Watson’s cognitive computing intelligence. In line with today’s announcement, IBM is launching the Watson Developers Cloud, where software application providers — ranging from start-ups to established technology leaders, such as MD Buyline — can collaborate with IBM to create Watson-powered apps. The cloud will feature a “sandbox” for app creation, as well as a developer toolkit, educational materials and access to IBM Watson’s application programming interface (API).

Starting with innovative businesses, such as MD Buyline, each partner in IBM’s new Watson-fueled ecosystem will have the tools, talent and expertise to execute on its vision, and in turn, bring to market a new class of cognitive innovations that transform how their users do business, make decisions and improve lives.

Healthcare providers currently make decisions about patient care, reimbursement and purchases based on vast amounts of decentralized, unstructured data (including but not limited to electronic medical records (EMR), spend data, claims, cost data, outcomes, quality, clinical trials and medical journals). This Big Data is valuable and necessary to the decisions hospitals and healthcare professionals make every day. But finding comprehensive, unbiased evidence is challenging and time-consuming.

In developing the Hippocrates solution, MD Buyline and IBM are training IBM Watson to extract, learn, assign context and understand information from various credible sources of Big Data. Hippocrates will be designed in a way that’s easy to use. When asked a question, Hippocrates calls upon Watson’s ability to understand natural language and human speech, and then use hypotheses and evidence-based learning to generate a confidence-weighted answer. Users can then share Hippocrates’ responses to collaborate with their peers and learn from first-hand experiences.

“Several areas of hospitals can benefit from the IBM Watson cognitive computing platform, including clinical and financial decision support, quality improvement, supply chain and C-suite,” said Satin Mirchandani, CEO of MD Buyline. “As the Accountable Care Organization (ACO) model of value-based payments converges with outcomes-based purchasing, the new Hippocrates platform presents hospitals with an opportunity to evaluate and improve quality, value, outcomes and patient satisfaction.”

With more than 30 years of industry experience and 3,300 member hospitals and healthcare systems nationwide, MD Buyline has accumulated an unparalleled amount of quality, objective and evidence-based data that provides hospitals with clinical and financial insight. MD Buyline’s clinical analysts have a deep understanding of existing and emerging technologies, price benchmarks, clinical effectiveness and much more, as well as deep-seated relationships within health systems. “With Hippocrates powered by IBM Watson, MD Buyline can enable a new era of efficiently providing hospitals with relevant evidence that enlightens and empowers users to support healthier decisions, hospitals and, ultimately, patients,” said Mirchandani.

IBM Watson: Then and Now

IBM’s mission to spark a new generation of Watson-powered apps is the latest milestone in the company’s initiative to develop cognitive system offerings that help its clients and partners succeed, in a range of industries including healthcare, financial services and retail.

Two years after its triumph on the television quiz show Jeopardy!, IBM Watson has evolved from a first-of-a-kind status, to a commercial cognitive computing system. Watson has gained a 240 percent improvement in system performance, and a reduction of 75 percent in the physical requirements needed to run the system which can now operate from a single Power 750 server with Linux and from a cloud computing environment.

Named after IBM founder Thomas J. Watson, IBM’s transformational cognitive technology was developed in IBM’s Research Labs. Using advances in natural language processing and analytics, Watson can process information similar to the way people think, representing a significant shift in the ability for organizations to quickly analyze, understand and respond to vast amounts of Big Data. The ability to use Watson to answer complex questions posed in natural language with speed, accuracy and confidence has enormous potential to improve decision making across a variety of industries from healthcare to retail, telecommunications and financial services.

About MD Buyline

Healthcare providers recognize MD Buyline as the leading provider of evidence-based information and research. By creating transparency and fostering consultative relationships, MD Buyline has partnered with providers for more than three decades to identify cost reduction opportunities. Providers rely on MD Buyline’s data and clinical analysts for financial and clinical insight to reach long- and short-term goals. For more information, please visit and follow MD Buyline on Twitter, @MDBuyline.

View images of Hippocrates powered by IBM Watson.

About IBM

For more information, please visit To join the social discussion about Watson, include the hashtag #ibmwatson.